Hypothalamic-pituitary-adrenal axis dysregulation in depersonalization disorder

Daphne Simeon, Orna Guralnik, Margaret Knutelska, Eric Hollander, James Schmeidler

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Background: The purpose of this preliminary study was to investigate HPA axis function in dissociation. Methods: Nine subjects with DSM-IV depersonalization disorder (DPD), without lifetime Posttraumatic Stress Disorder (PTSD) or current major depression, were compared to nine healthy comparison (HC) subjects of comparable age and gender. Results: DPD subjects demonstrated significant hyposuppression to low-dose dexamethasone administration and significantly elevated morning plasma cortisol levels when covaried for depression scores, but no difference in 24-hour urinary cortisol excretion. Dissociation scores powerfully predicted suppression whereas depression scores did not contribute to the prediction. Conclusions: Primary dissociative conditions, such as depersonalization disorder, may be associated with a pattern of HPA axis dysregulation that differs from PTSD and merits further study.

Original languageEnglish (US)
Pages (from-to)793-795
Number of pages3
JournalNeuropsychopharmacology
Volume25
Issue number5
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Depersonalization
Dissociative Disorders
Depression
Post-Traumatic Stress Disorders
Hydrocortisone
Diagnostic and Statistical Manual of Mental Disorders
Dexamethasone
Healthy Volunteers

Keywords

  • Cortisol
  • Depersonalization
  • Dexamethasone
  • Dissociation
  • HPA axis
  • Suppression

ASJC Scopus subject areas

  • Pharmacology

Cite this

Hypothalamic-pituitary-adrenal axis dysregulation in depersonalization disorder. / Simeon, Daphne; Guralnik, Orna; Knutelska, Margaret; Hollander, Eric; Schmeidler, James.

In: Neuropsychopharmacology, Vol. 25, No. 5, 2001, p. 793-795.

Research output: Contribution to journalArticle

Simeon, Daphne ; Guralnik, Orna ; Knutelska, Margaret ; Hollander, Eric ; Schmeidler, James. / Hypothalamic-pituitary-adrenal axis dysregulation in depersonalization disorder. In: Neuropsychopharmacology. 2001 ; Vol. 25, No. 5. pp. 793-795.
@article{d036ecbd20a74ae4aa45791af648c628,
title = "Hypothalamic-pituitary-adrenal axis dysregulation in depersonalization disorder",
abstract = "Background: The purpose of this preliminary study was to investigate HPA axis function in dissociation. Methods: Nine subjects with DSM-IV depersonalization disorder (DPD), without lifetime Posttraumatic Stress Disorder (PTSD) or current major depression, were compared to nine healthy comparison (HC) subjects of comparable age and gender. Results: DPD subjects demonstrated significant hyposuppression to low-dose dexamethasone administration and significantly elevated morning plasma cortisol levels when covaried for depression scores, but no difference in 24-hour urinary cortisol excretion. Dissociation scores powerfully predicted suppression whereas depression scores did not contribute to the prediction. Conclusions: Primary dissociative conditions, such as depersonalization disorder, may be associated with a pattern of HPA axis dysregulation that differs from PTSD and merits further study.",
keywords = "Cortisol, Depersonalization, Dexamethasone, Dissociation, HPA axis, Suppression",
author = "Daphne Simeon and Orna Guralnik and Margaret Knutelska and Eric Hollander and James Schmeidler",
year = "2001",
doi = "10.1016/S0893-133X(01)00288-3",
language = "English (US)",
volume = "25",
pages = "793--795",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Hypothalamic-pituitary-adrenal axis dysregulation in depersonalization disorder

AU - Simeon, Daphne

AU - Guralnik, Orna

AU - Knutelska, Margaret

AU - Hollander, Eric

AU - Schmeidler, James

PY - 2001

Y1 - 2001

N2 - Background: The purpose of this preliminary study was to investigate HPA axis function in dissociation. Methods: Nine subjects with DSM-IV depersonalization disorder (DPD), without lifetime Posttraumatic Stress Disorder (PTSD) or current major depression, were compared to nine healthy comparison (HC) subjects of comparable age and gender. Results: DPD subjects demonstrated significant hyposuppression to low-dose dexamethasone administration and significantly elevated morning plasma cortisol levels when covaried for depression scores, but no difference in 24-hour urinary cortisol excretion. Dissociation scores powerfully predicted suppression whereas depression scores did not contribute to the prediction. Conclusions: Primary dissociative conditions, such as depersonalization disorder, may be associated with a pattern of HPA axis dysregulation that differs from PTSD and merits further study.

AB - Background: The purpose of this preliminary study was to investigate HPA axis function in dissociation. Methods: Nine subjects with DSM-IV depersonalization disorder (DPD), without lifetime Posttraumatic Stress Disorder (PTSD) or current major depression, were compared to nine healthy comparison (HC) subjects of comparable age and gender. Results: DPD subjects demonstrated significant hyposuppression to low-dose dexamethasone administration and significantly elevated morning plasma cortisol levels when covaried for depression scores, but no difference in 24-hour urinary cortisol excretion. Dissociation scores powerfully predicted suppression whereas depression scores did not contribute to the prediction. Conclusions: Primary dissociative conditions, such as depersonalization disorder, may be associated with a pattern of HPA axis dysregulation that differs from PTSD and merits further study.

KW - Cortisol

KW - Depersonalization

KW - Dexamethasone

KW - Dissociation

KW - HPA axis

KW - Suppression

UR - http://www.scopus.com/inward/record.url?scp=0034773113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034773113&partnerID=8YFLogxK

U2 - 10.1016/S0893-133X(01)00288-3

DO - 10.1016/S0893-133X(01)00288-3

M3 - Article

VL - 25

SP - 793

EP - 795

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 5

ER -